AstraZeneca Earnings Hit By Higher Costs
Wall Street Journal
AstraZeneca reported core earnings for the fourth quarter just short of consensus, but said it expected double-digit percentage growth in 2024.
https://www.wsj.com/articles/astrazeneca-azn-q4-earnings-report-2023-ca5eb4ad